(Q36036687)

11 August 2017

1 reference

title

Reduced haloperidol: a factor in determining the therapeutic benefit of haloperidol treatment? (English)

1 reference

11 August 2017

1 reference

W. H. Chang

1

1 reference

PubMed ID

1570373

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1570373

10 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

PubMed ID

1570373

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1570373

10 October 2022

publication date

1 January 1992

1 reference

11 August 2017

8

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

11 August 2017

106

1 reference

11 August 2017

3

1 reference

11 August 2017

289-296

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02245407

11 August 2017

0 references

cites work

Extrapyramidal reactions in Asians

1 reference

https://api.crossref.org/works/10.1007%2FBF02245407

Substantial rise in sparteine metabolic ratio during haloperidol treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245407

The interpretation of plasma haloperidol concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245407

Neuroleptic dosage for Asians: a failure to replicate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245407

Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245407

Simultaneous determination of haloperidol and its reduced metabolite in serum and plasma by isocratic liquid chromatography with electrochemical detection

21 January 2018

1 reference

12 December 2020

Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance

1 reference

12 December 2020

Plasma level monitoring of antipsychotic drugs. Clinical utility

1 reference

12 December 2020

Intersubject variation in the pharmacokinetics of haloperidol and reduced haloperidol

1 reference

12 December 2020

Possible interference by the reduced haloperidol metabolite with the radioimmunoassay and radioreceptor assay of blood haloperidol

1 reference

12 December 2020

Reduced Haloperidol/Haloperidol ratio and clinical outcome in schizophrenia: Preliminary evidences

1 reference

12 December 2020

Haloperidol concentrations elevated in Chinese patients

1 reference

12 December 2020

Bioavailability of psychotropic drugs: historical perspective and pharmacokinetic overview.

1 reference

12 December 2020

Low plasma reduced haloperidol/haloperidol ratios in Chinese patients

1 reference

12 December 2020

Reduced haloperidol in the post-mortem brains of haloperidol-treated patients

1 reference

12 December 2020

Use of antisera in the isolation of human specific conjugates of haloperidol

1 reference

12 December 2020

Interconversions between haloperidol and reduced haloperidol in schizophrenic patients and guinea pigs: a steady-state study

1 reference

12 December 2020

Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients

1 reference

12 December 2020

Electrophysiological interactions between haloperidol and reduced haloperidol, and dopamine, norepinephrine and phencyclidine in rat brain.

1 reference

12 December 2020

Reversible metabolism of haloperidol and reduced haloperidol in Chinese schizophrenic patients

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients

1 reference

12 December 2020

Rapid formation of reduced haloperidol in guinea pigs following haloperidol administration.

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in guinea pigs

1 reference

12 December 2020

Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity?

1 reference

12 December 2020

Prolactin releasing potencies of antipsychotic and related nonantipsychotic compounds in female rats: relation to clinical potencies

1 reference

12 December 2020

Time-response curves of homovanillic acid in caudate and pre-frontal cortex following acute neuroleptic administration.

1 reference

12 December 2020

Dose-dependent reduced haloperidol/haloperidol ratios in schizophrenic patients

1 reference

12 December 2020

Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D-2 receptors

1 reference

12 December 2020

Haloperidol reduction can be assayed in human red blood cells

1 reference

12 December 2020

Reduced haloperidol: Effects on striatal dopamine metabolism and conversion to haloperidol in the rat

1 reference

12 December 2020

Reduced haloperidol and haloperidol: effects on homovanillic acid in caudate and prefrontal cortex.

1 reference

12 December 2020

Serum haloperidol concentration and clinical response in schizophrenia

1 reference

12 December 2020

Haloperidol reductase in human and guinea pig livers

1 reference

12 December 2020

Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia

1 reference

12 December 2020

Biliary excretion of reduced haloperidol glucuronide

1 reference

12 December 2020

Interconversion between haloperidol and reduced haloperidol in healthy volunteers

1 reference

12 December 2020

Haloperidol and reduced haloperidol plasma levels in Chinese vs. non-Chinese psychiatric patients

1 reference

12 December 2020

The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits

1 reference

12 December 2020

Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients

1 reference

12 December 2020

Review of haloperidol blood level and clinical response: looking through the window

1 reference

12 December 2020

Interconversion between haloperidol and reduced haloperidol in humans

1 reference

12 December 2020

Neuroleptic dosage for Asians

1 reference

12 December 2020

Reduced haloperidol/haloperidol ratios in plasma: polymorphism in Japanese psychiatric patients.

1 reference

12 December 2020

Measurement of haloperidol reductase activity in red blood cells and reduced haloperidol/haloperidol ratios in plasma in oriental psychiatric patients

1 reference

12 December 2020

Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data.

1 reference

12 December 2020

Interconversions of haloperidol and reduced haloperidol in guinea pig and rat liver microsomes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245407

1 reference

11 August 2017

1 reference

PubMed ID

1570373